Tag Archives: INGN

Top 10 Performing Stocks To Own For 2019

Leave a reply

Wynn Resorts (NASDAQ:WYNN) has been on a growth tear since opening Wynn Palace in Macau two years ago, but that’s not the end of the company’s ambitions. There’s room to expand in existing markets like Las Vegas and Macau, and new markets to conquer like Boston and Japan. 

The company’s second-quarter 2018 earnings conference call on Aug. 1 provided a lot of insight into how management is viewing growth opportunities and where it’s allocating capital for the future. 

Image source: Getty Images.

Macau still has room for growth

Wynn Palace is now Wynn Resorts’ best-performing property with $179.3 million of property EBITDA in the second quarter of 2018, but it isn’t as big as it can be, given 7 acres of undeveloped land adjacent to the existing site. CEO Matt Maddox stated that he has big plans for the land, with potential for another entertainment feature Wynn Resorts is known for: 

Top 10 Performing Stocks To Own For 2019: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Heath Lukatch sold 500 shares of the firm’s stock in a transaction that occurred on Friday, October 5th. The shares were sold at an average price of $218.23, for a total value of $109,115.00. Following the sale, the director now owns 1,489 shares of the company’s stock, valued at approximately $324,944.47. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Jon C. Ogg]

    Inogen Inc. (NASDAQ: INGN) was downgraded to Buy from Strong Buy at Needham.

    Neurocrine Biosciences Inc. (NASDAQ: NBIX) was started as Overweight and assigned a $145 target price (versus a $116.93 close) at Morgan Stanley.

Top 10 Performing Stocks To Own For 2019: Friedman Industries Inc.(FRD)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Farad (CURRENCY:FRD) traded 24.6% higher against the dollar during the twenty-four hour period ending at 14:00 PM E.T. on June 28th. Farad has a market capitalization of $825,559.00 and approximately $54.00 worth of Farad was traded on exchanges in the last day. In the last seven days, Farad has traded up 3.4% against the dollar. One Farad token can currently be bought for about $0.0061 or 0.00000100 BTC on exchanges.

  • [By Stephan Byrd]

    Friedman Industries (NYSEAMERICAN:FRD) issued its quarterly earnings data on Tuesday. The company reported $0.51 earnings per share for the quarter, Bloomberg Earnings reports. The firm had revenue of $48.19 million for the quarter. Friedman Industries had a return on equity of 2.05% and a net margin of 1.19%.

Top 10 Performing Stocks To Own For 2019: Star Bulk Carriers Corp.(SBLK)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Star Bulk Carriers (NASDAQ:SBLK) had its price target boosted by Morgan Stanley from $14.00 to $15.00 in a report issued on Wednesday morning. Morgan Stanley currently has an overweight rating on the shipping company’s stock.

  • [By Motley Fool Staff]

    Star Bulk Carriers (NASDAQ:SBLK) Q1 2018 Earnings Conference CallJun. 12, 2018 11:00 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Star Bulk Carriers (SBLK)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Performing Stocks To Own For 2019: CHS Inc(CHSCO)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media headlines about CHS Inc Preferred Shares Class B (NASDAQ:CHSCO) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. CHS Inc Preferred Shares Class B earned a media sentiment score of 0.24 on Accern’s scale. Accern also assigned news articles about the company an impact score of 45.8637910025833 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

Top 10 Performing Stocks To Own For 2019: Tandem Diabetes Care, Inc.(TNDM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    World Fuel Services Corporation (NYSE: INT) tumbled 18 percent to $22.90 following Q1 results.
    Biglari Holdings Inc. (NYSE: BH) fell 17.4 percent to $349.52. Washington Prime Group will replace Biglari Holdings in the S&P SmallCap 600 on Tuesday, May 1.
    Flex Ltd. (NASDAQ: FLEX) dipped 15.7 percent to $14.03 after a mixed fourth quarter report.
    FormFactor, Inc. (NASDAQ: FORM) fell 15.3 percent to $11.65. FormFactor is expected to release Q1 results on May 2.
    Data I/O Corporation (NASDAQ: DAIO) dropped 14.3 percent to $6.24 following Q1 results.
    National Instruments Corporation (NASDAQ: NATI) fell 14.3 percent to $ 42.34 after reporting Q1 results.
    United States Steel Corporation (NYSE: X) dipped 14.2 percent to $32.37 following Q1 results.
    Civeo Corporation (NYSE: CVEO) dropped 13.5 percent to $3.33. Civeo posted a Q1 loss of $0.42 per share on sales of $101.504 million.
    athenahealth, Inc. (NASDAQ: ATHN) fell 12.4 percent to $125.310 after reporting Q1 results.
    Charter Communications, Inc. (NASDAQ: CHTR) shares tumbled 12.1 percent to $262.06 as the company posted Q1 results.
    Value Line, Inc. (NASDAQ: VALU) fell 11.3 percent to $19.10.
    Federated Investors, Inc. (NYSE: FII) shares dropped 11.2 percent to $27.605 after the company posted downbeat quarterly earnings.
    AV Homes, Inc. (NASDAQ: AVHI) declined 10.7 percent to $17.20 following Q1 results.
    CalAmp Corp. (NASDAQ: CAMP) dropped 9.4 percent to $21.01 after reporting Q4 results.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) shares fell 8.9 percent to $7.280 following mixed Q1 results.
    Sony Corporation (NYSE: SNE) shares fell 8.4 percent to $45.97 after reporting Q4 results.
    LogMeIn Inc (NASDAQ: LOGM) fell 8.2 percent to $109.825. LogMeIn reported upbeat earnings for its first quarter, but issued weak second quarter and FY18 earning guidance.
    Eleven Biotherapeutics, Inc. (NASDAQ: EBIO

  • [By Max Byerly]

    Anika Therapeutics (NASDAQ: TNDM) and Tandem Diabetes Care (NASDAQ:TNDM) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, valuation, profitability, earnings, risk and analyst recommendations.

  • [By Jon C. Ogg]

    Tandem Diabetes Care Inc. (NASDAQ: TNDM) was raised to Neutral from Underperform with a $45 price objective (versus a $38.61 close) at Merrill Lynch.

  • [By Keith Speights]

    Shares of Tandem Diabetes Care (NASDAQ:TNDM) were 10.9% higher as of 2:42 p.m. EDT on Thursday. Investors continued to drive up the insulin-pump maker’s stock following Tandem’s second-quarter update on Monday after the market closed. Tandem’s share price has risen more than 27% since the company announced its Q2 results.

  • [By Lisa Levin] Gainers
    Precipio, Inc. (NASDAQ: PRPO) jumped 43.3 percent to $0.5447 after the micro-cap specialty diagnostics company reported preliminary first-quarter results. The company said its first quarter revenue rose 286 percent from the same quarter a year ago to $712,000.
    Galectin Therapeutics, Inc. (NASDAQ: GALT) gained 34.5 percent to $4.52 after the company announced it would proceed with Phase 3 development of GR-MD-02 for NASH Cirrhosis following the FDA meeting.
    Boxlight Corporation (NASDAQ: BOXL) shares rose 21.9 percent to $8.1063.
    Evolus, Inc. (NASDAQ: EOLS) shares surged 16 percent to $15.65.
    Myomo, Inc. (NYSE: MYO) shares jumped 15.5 percent to $3.6263 after the company disclosed that its application for Medicare codes received favorable preliminary decision.
    Tandem Diabetes Care, Inc. (NASDAQ: TNDM) rose 13.7 percent to $10.12.
    ProPhase Labs, Inc. (NASDAQ: PRPH) gained 13.7 percent to $4.6743.
    Acacia Communications, Inc. (NASDAQ: ACIA) shares gained 12.2 percent to $35.34 as optical sector is seeing strength following President Trump's announcement that he would work with China related to ZTE Corp.
    Tailored Brands, Inc. (NYSE: TLRD) shares rose 11.3 percent to $35.17. Jefferies upgraded Tailored Brands from Hold to Buy.
    Kona Grill, Inc. (NASDAQ: KONA) jumped 10.6 percent to $2.875.
    Federated National Holding Company (NASDAQ: FNHC) shares rose 10.6 percent to $20.29. Raymond James upgraded Federated National Holding from Outperform to Strong Buy.
    Renewable Energy Group, Inc. (NASDAQ: REGI) climbed 10.2 percent to $15.15. Renewable Energy will replace Synchronoss Technologies Inc. (NASDAQ: SNCR) in the S&P SmallCap 600 on Tuesday, May 15.
    Stein Mart, Inc. (NASDAQ: SMRT) shares climbed 10.1 percent to $3.16. Stein Mart is expected to release Q1 earnings on May 23.
    NXP Semiconductors N.V. (NASDAQ: NXPI) rose 9.7 percent to $108.60 after Bloomberg reported that the China’s Commerce Ministry has restar
  • [By Todd Campbell]

    It’s not just drugmakers that are disrupting the massive diabetes market. Medical device makers are also developing new approaches that can help diabetics better control their disease. From medtech Goliaths Medtronic (NYSE:MDT) and Abbott Labs (NYSE:ABT) to small pure plays Dexcom (NASDAQ:DXCM), Insulet Corp. (NASDAQ:PODD), and Tandem Diabetes Care (NASDAQ:TNDM), we’ve got you covered.

Top 10 Performing Stocks To Own For 2019: ESSA Pharma Inc.(EPIX)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin]

     

    Losers
    Heat Biologics, Inc. (NASDAQ: HTBX) shares tumbled 48.59 percent to close at $1.275 on Thursday after the company priced its $18,000,000 public offering.
    InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) fell 38.77 percent to close at $8.26 on Thursday.
    Check-Cap Ltd. (NASDAQ: CHEK) shares tumbled 27.43 percent to close at $8.81.
    Achaogen, Inc. (NASDAQ: AKAO) dropped 24.76 percent to close at $11.06 in reaction to a disappointing update from an FDA AdCom panel. The FDA panel voted favorably for the company's Plazcomicin for treatment of adults with complicated urinary tract infections, but also voted against the therapy to be used as a treatment for bloodstream infections.
    Anika Therapeutics, Inc. (NASDAQ: ANIK) shares declined 24.68 percent to close at $34.80 after the company posted downbeat quarterly results.
    LSC Communications, Inc. (NASDAQ: LKSD) shares fell 24.22 percent to close at $12.64 following wider-than-expected Q1 loss.
    Cardinal Health, Inc. (NYSE: CAH) fell 21.42 percent to close at $50.80 following downbeat quarterly profit.
    Horizon Global Corporation (NYSE: HZN) dropped 20.42 percent to close at $6.00 following downbeat quarterly earnings.
    Hornbeck Offshore Services, Inc. (NYSE: HOS) slipped 20.11 percent to close at $2.90 following wider-than-expected Q1 loss.
    Esperion Therapeutics, Inc. (NASDAQ: ESPR) fell 19.28 percent to close at $36.93. Esperion Therapeutics stock lost roughly a third of its value Wednesday after the company reported mixed Phase III results for its leading drug candidate, bempedoic acid. JP Morgan downgraded Esperion Therapeutics from Neutral to Underweight.
    Laredo Petroleum, Inc. (NYSE: LPI) declined 17.77 percent to close at $8.98 after the company reported weaker-than-expected Q1 earnings.
    The Habit Restaurants, Inc. (NASDAQ: HABT) dipped 16.1 percent to close at $8.60 after the company reported downbeat quarterly results.
    Arcadia Biosciences, Inc. (N

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on ESSA Pharma (EPIX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Stephan Byrd]

    Avid Bioservices (NASDAQ:CDMO) and ESSA Pharma (NASDAQ:EPIX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, risk, dividends, institutional ownership and profitability.

Top 10 Performing Stocks To Own For 2019: Fortive Corporation (FTV)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Get a free copy of the Zacks research report on Fortive (FTV)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Motley Fool Transcribers]

    Fortive Corporation  (NYSE:FTV)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:30 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Ethan Ryder]

    Caption Management LLC bought a new stake in shares of Fortive Corp (NYSE:FTV) in the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 18,000 shares of the technology company’s stock, valued at approximately $1,388,000.

  • [By Max Byerly]

    Fortive Corp (NYSE:FTV) shares hit a new 52-week high during trading on Monday . The company traded as high as $87.72 and last traded at $87.43, with a volume of 180580 shares trading hands. The stock had previously closed at $87.03.

  • [By Stephan Byrd]

    Geneva Partners LLC lowered its position in Fortive Corp (NYSE:FTV) by 71.2% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,270 shares of the technology company’s stock after selling 25,357 shares during the quarter. Geneva Partners LLC’s holdings in Fortive were worth $792,000 at the end of the most recent reporting period.

  • [By Ethan Ryder]

    Fortive Corp (NYSE:FTV) has earned an average rating of “Buy” from the fourteen brokerages that are currently covering the stock, MarketBeat reports. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1-year target price among brokers that have covered the stock in the last year is $81.00.

Top 10 Performing Stocks To Own For 2019: I.D. Systems, Inc.(IDSY)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    Here are some of the headlines that may have impacted Accern Sentiment’s rankings:

    Get I.D. Systems alerts:

    I.D. Systems, Inc. (IDSY) Expected to Announce Quarterly Sales of $12.32 Million (americanbankingnews.com) I.D. Systems, Inc. (IDSY) Expected to Announce Earnings of $0.01 Per Share (americanbankingnews.com) I.D. Systems integrates Keytroller, forms PowerFleet division (mmh.com) I.D. Systems Integrates Keytroller and Forms PowerFleet® Division Focused on Industrial Truck Management Systems (finance.yahoo.com)

    Several analysts have commented on IDSY shares. National Securities started coverage on shares of I.D. Systems in a research note on Monday, August 27th. They issued a “buy” rating and a $8.60 price target on the stock. ValuEngine upgraded shares of I.D. Systems from a “sell” rating to a “hold” rating in a research note on Thursday, June 7th. Finally, Zacks Investment Research downgraded shares of I.D. Systems from a “hold” rating to a “sell” rating in a report on Wednesday, August 15th. Two analysts have rated the stock with a sell rating and five have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus target price of $9.32.

  • [By Shane Hupp]

    TRADEMARK VIOLATION NOTICE: “I.D. Systems, Inc. (IDSY) Major Shareholder Purchases $381,042.60 in Stock” was posted by Ticker Report and is the sole property of of Ticker Report. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at www.tickerreport.com/banking-finance/4125843/i-d-systems-inc-idsy-major-shareholder-purchases-381042-60-in-stock.html.

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on I.D. Systems (IDSY)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    xG Technology (NASDAQ: XGTI) and I.D. Systems (NASDAQ:IDSY) are both small-cap computer and technology companies, but which is the superior investment? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, profitability and dividends.

Top 10 Performing Stocks To Own For 2019: Liberty Tax, Inc.(TAX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Acacia Research (NASDAQ: ACTG) and Liberty Tax (NASDAQ:TAX) are both small-cap business services companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, profitability, risk, earnings and valuation.

Top 10 Performing Stocks To Own For 2019: TrueBlue Inc.(TBI)

Advisors’ Opinion:

  • [By Motley Fool Transcribers]

    TrueBlue Inc  (NYSE:TBI)Q4 2018 Earnings Conference CallFeb. 07, 2019, 5:00 p.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Logan Wallace]

    Trueblue (NYSE: TBI) is one of 23 public companies in the “Help supply services” industry, but how does it contrast to its rivals? We will compare Trueblue to similar businesses based on the strength of its analyst recommendations, institutional ownership, valuation, profitability, dividends, earnings and risk.

  • [By Logan Wallace]

    Media stories about Trueblue (NYSE:TBI) have trended somewhat positive on Monday, according to Accern Sentiment. The research firm rates the sentiment of news coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Trueblue earned a media sentiment score of 0.09 on Accern’s scale. Accern also assigned media stories about the business services provider an impact score of 45.3296498009881 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near future.

  • [By Joseph Griffin]

    Trueblue Inc (NYSE:TBI) has received a consensus rating of “Hold” from the six brokerages that are currently covering the firm, MarketBeat.com reports. Two investment analysts have rated the stock with a sell recommendation and three have assigned a hold recommendation to the company. The average twelve-month target price among brokerages that have issued a report on the stock in the last year is $27.50.

  • [By Max Byerly]

    Connor Clark & Lunn Investment Management Ltd. lifted its holdings in Trueblue Inc (NYSE:TBI) by 18.2% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 30,550 shares of the business services provider’s stock after purchasing an additional 4,700 shares during the period. Connor Clark & Lunn Investment Management Ltd.’s holdings in Trueblue were worth $823,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Trueblue (TBI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now

Leave a reply

Meet the Annuity Trust on Bernie Sanders Hit List

How to Get Medicaid for Nursing Home Care Without Going Broke

10 States Where the Millennials Are More Obese Than the Seniors

The $475,000 price tag on Novartis AG’s latest breakthrough cancer therapy came under fire from one of the biggest managers of drug costs in the United States, underscoring the challenges the Swiss drugmaker will face in promoting the potential blockbuster.

The cost of the leukemia treatment, called Kymriah, is “dramatically higher” than other such complex treatments, and the health care system isn’t ready to pay for it, Steve Miller, chief medical officer at Express Scripts Holding Co., said Thursday in a blog post on his company’s website. Gene therapies like Novartis’s are targeted at a small number of patients and typically used just once, meaning that drug companies have limited chances to recoup their investment.

“Therein lies the challenge,” Miller wrote. “We need a new payment model.”

Top 10 Medical Stocks To Invest In Right Now: Aqua America, Inc.(WTR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Connecticut Water Service (NASDAQ: CTWS) and Aqua America (NYSE:WTR) are both utilities companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, earnings and valuation.

  • [By ]

    Cramer was bearish on United States Steel (X) , Teva Pharmaceuticals (TEVA) , Aqua America (WTR) and Mueller Water Products (MWA) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Shane Hupp]

    Duff & Phelps Investment Management Co. reduced its stake in shares of Aqua America (NYSE:WTR) by 7.1% during the first quarter, Holdings Channel reports. The institutional investor owned 95,640 shares of the utilities provider’s stock after selling 7,290 shares during the quarter. Duff & Phelps Investment Management Co.’s holdings in Aqua America were worth $3,257,000 at the end of the most recent quarter.

  • [By Ethan Ryder]

    ValuEngine upgraded shares of Aqua America (NYSE:WTR) from a hold rating to a buy rating in a report released on Friday.

    Several other analysts also recently weighed in on the stock. Zacks Investment Research upgraded shares of Aqua America from a hold rating to a buy rating and set a $41.00 price objective on the stock in a research report on Monday, January 15th. Wells Fargo downgraded shares of Aqua America from an outperform rating to a market perform rating and dropped their price target for the stock from $43.00 to $37.00 in a research report on Monday, February 26th. UBS began coverage on shares of Aqua America in a research report on Thursday, March 8th. They set a neutral rating and a $36.00 price target on the stock. Finally, Boenning Scattergood restated a neutral rating on shares of Aqua America in a research report on Tuesday, April 24th. Seven equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The company presently has a consensus rating of Hold and a consensus target price of $38.29.

  • [By Joseph Griffin]

    Aqua America (NYSE: WTR) and SJW Group (NYSE:SJW) are both utilities companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, earnings, analyst recommendations, valuation and risk.

  • [By ]

    Aqua America (WTR) : “This is not the stock for a hot economy, even though this is a well-run company.”

    Mueller Water Products (MWA) : “This is not the time to buy. I don’t like the numbers.”

Top 10 Medical Stocks To Invest In Right Now: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    For example, I used finvizin the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Max Byerly]

    Swiss National Bank grew its holdings in HealthEquity (NASDAQ:HQY) by 3.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 88,800 shares of the company’s stock after purchasing an additional 2,900 shares during the quarter. Swiss National Bank owned approximately 0.15% of HealthEquity worth $5,376,000 at the end of the most recent quarter.

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider ofTaser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-ledpayroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE)– The company’s push to the cloud is drivingdouble-digitgains in revenue and profits. AppFolio (NASDAQ: APPF) — Asoftware-as-a-service provider focused on servicing business owners in severalniche markets. BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century.

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here.

  • [By Max Byerly]

    ValuEngine upgraded shares of HealthEquity (NASDAQ:HQY) from a buy rating to a strong-buy rating in a research report report published on Tuesday morning.

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

Top 10 Medical Stocks To Invest In Right Now: Genesis Energy, L.P.(GEL)

Advisors’ Opinion:

  • [By Joseph Griffin]

    Stifel Financial Corp cut its stake in shares of Genesis Energy, L.P. common stock (NYSE:GEL) by 1.7% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 450,749 shares of the pipeline company’s stock after selling 7,788 shares during the quarter. Stifel Financial Corp owned about 0.37% of Genesis Energy, L.P. common stock worth $8,884,000 as of its most recent SEC filing.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Genesis Energy, L.P. common stock (GEL)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Blair William & Co. IL cut its stake in Genesis Energy, L.P. common stock (NYSE:GEL) by 21.6% in the first quarter, HoldingsChannel.com reports. The fund owned 55,817 shares of the pipeline company’s stock after selling 15,409 shares during the period. Blair William & Co. IL’s holdings in Genesis Energy, L.P. common stock were worth $1,100,000 as of its most recent filing with the Securities and Exchange Commission.

Top 10 Medical Stocks To Invest In Right Now: Compass Diversified Holdings(CODI)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Schroder Investment Management Group grew its stake in Compass Diversified Holdings (NYSE:CODI) by 3.2% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,097,576 shares of the financial services provider’s stock after purchasing an additional 33,776 shares during the period. Schroder Investment Management Group owned approximately 1.83% of Compass Diversified worth $18,000,000 at the end of the most recent reporting period.

Top 10 Medical Stocks To Invest In Right Now: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Shane Hupp]

    Here are some of the news articles that may have impacted Accern Sentiment’s analysis:

    Get Inogen alerts:

    Comparing Halyard Health (HYH) and Inogen (INGN) (americanbankingnews.com) ‘The stock market has sucked on nitrous oxide’ Wall… (beaumontenterprise.com) EPS Calculations to Consider Inogen Inc (NASDAQ: INGN) (stocksmarketcap.com) Inogen’s shares drop on short seller Citron’s tweet (reuters.com) Inogen Hit By Citron Report; Analyst Rebuttal Calls This ‘An Excellent Entry Point’ (msn.com)

    Several equities analysts recently issued reports on the company. JPMorgan Chase & Co. raised their price target on Inogen from $150.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, May 1st. Leerink Swann restated an “outperform” rating and set a $170.00 price target (up from $150.00) on shares of Inogen in a research report on Tuesday, May 1st. ValuEngine upgraded Inogen from a “buy” rating to a “strong-buy” rating in a research report on Wednesday, May 2nd. Zacks Investment Research upgraded Inogen from a “hold” rating to a “buy” rating and set a $131.00 price target on the stock in a research report on Tuesday, February 13th. Finally, BidaskClub upgraded Inogen from a “hold” rating to a “buy” rating in a research report on Friday, March 9th. One equities research analyst has rated the stock with a hold rating, three have given a buy rating and three have issued a strong buy rating to the company. Inogen has an average rating of “Buy” and an average target price of $178.00.

  • [By Ethan Ryder]

    Inogen Inc (NASDAQ:INGN) Director Ray Benjamin M. Anderson sold 1,000 shares of the company’s stock in a transaction dated Monday, July 2nd. The stock was sold at an average price of $184.88, for a total value of $184,880.00. Following the completion of the transaction, the director now owns 1,989 shares in the company, valued at $367,726.32. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

  • [By Logan Wallace]

    Rock Springs Capital Management LP lifted its stake in shares of Inogen Inc (NASDAQ:INGN) by 38.1% during the first quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 110,500 shares of the medical technology company’s stock after purchasing an additional 30,500 shares during the quarter. Rock Springs Capital Management LP owned 0.52% of Inogen worth $13,574,000 as of its most recent SEC filing.

  • [By Logan Wallace]

    Inogen Inc (NASDAQ:INGN) EVP Byron Myers sold 1,846 shares of the business’s stock in a transaction dated Monday, June 18th. The stock was sold at an average price of $190.04, for a total transaction of $350,813.84. Following the sale, the executive vice president now owns 39,121 shares in the company, valued at $7,434,554.84. The transaction was disclosed in a legal filing with the SEC, which is available at this link.

Top 10 Medical Stocks To Invest In Right Now: RELX N.V.(RENX)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on Relx (RENX)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about American Financial Group (NYSE:AFG) have been trending somewhat positive this week, Accern Sentiment Analysis reports. The research group identifies negative and positive news coverage by reviewing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. American Financial Group earned a media sentiment score of 0.25 on Accern’s scale. Accern also assigned press coverage about the insurance provider an impact score of 46.840441381164 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the next several days.

  • [By Joseph Griffin]

    Westpac Banking Corp increased its stake in shares of American Financial Group (NYSE:AFG) by 10.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 7,403 shares of the insurance provider’s stock after purchasing an additional 709 shares during the quarter. Westpac Banking Corp’s holdings in American Financial Group were worth $831,000 as of its most recent filing with the SEC.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on American Financial Group (AFG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: OneMain Holdings, Inc.(OMF)

Advisors’ Opinion:

  • [By Max Byerly]

    Rhumbline Advisers boosted its position in shares of OneMain Holdings Inc (NYSE:OMF) by 18.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 59,772 shares of the financial services provider’s stock after acquiring an additional 9,479 shares during the period. Rhumbline Advisers’ holdings in OneMain were worth $1,790,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Max Byerly]

    OneMain (NYSE: OMF) and Provident Financial (OTCMKTS:FPLPY) are both finance companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, dividends, earnings, profitability, analyst recommendations, valuation and risk.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on OneMain (OMF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In Right Now: SPDR S&P Biotech ETF (XBI)

Advisors’ Opinion:

  • [By ]

    In a sea of red, small-cap biotech stocks stood strong during Wednesdays trading session. The SPDR S&P Biotech ETF (NYSE:XBI) finished the day higher by more than 1.25% while the Nasdaq Composite was stuck in the red. XBIs comeback rally that began to materialize just before Christmas is now threatening to break out to new highs.

  • [By Money Morning News Team]

    But the biotech sector crushed the market, with the SPDR S&P Biotech ETF (NYSE: XBI) returning a market-beating 43.36% in 2017, nearly double the broader S&P 500.

  • [By Jim Crumly]

    Technology was the weakest sector, with biotech and semiconductor stocks in particular having a tough day. TheSPDR S&P Biotech ETF (NYSEMKT:XBI) tumbled 3.2% and theiShares PHLX Semiconductor ETF (NASDAQ:SOXX) lost 2.4%.

  • [By ]

    More importantly, the SPDR S&P Biotech ETF (NYSE:XBI) has proven resilient during the volatility spike and selloff.

    In fact, XBI never closed significantly below its 50-day moving average as investors dumped stocks. That turned out to be a huge tell

Top 10 Medical Stocks To Invest In Right Now: Energy Fuels Inc(UUUU)

Advisors’ Opinion:

  • [By Logan Wallace]

    Old West Investment Management LLC purchased a new stake in Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) in the first quarter, HoldingsChannel reports. The firm purchased 578,496 shares of the basic materials company’s stock, valued at approximately $1,003,000.

  • [By Stephan Byrd]

    Energy Fuels (NYSEAMERICAN:UUUU) (TSE:EFR) shares saw an uptick in trading volume on Monday . 1,091,365 shares were traded during mid-day trading, an increase of 300% from the previous session’s volume of 272,846 shares.The stock last traded at $2.09 and had previously closed at $2.04.

  • [By Stephan Byrd]

    Energy Fuels Inc (NYSEAMERICAN:UUUU) (TSE:EFR) was the recipient of a large increase in short interest during the month of June. As of June 15th, there was short interest totalling 2,265,513 shares, an increase of 19.6% from the May 31st total of 1,893,582 shares. Based on an average daily volume of 589,166 shares, the days-to-cover ratio is presently 3.8 days. Approximately 3.3% of the shares of the stock are short sold.

Hot Performing Stocks To Watch For 2018

Leave a reply

Small cap restaurant and entertainment stockDave & Busters Entertainment Inc (NASDAQ: PLAY) reported Q2 2017 earnings after the Tuesday close with shares falling in after hours/premarket trading. Total revenues increased 14.9% to $280.8 million as comparable store sales increased 1.1%. Across all stores, Food and Beverage revenues increased 10.2% to $118.7 million from $107.7 million and Amusement and Other revenues increased 18.6% to $162.1 million from $136.7 million. Food and Beverage represented 42.3% of total revenues while Amusements and Other represented 57.7% of total revenues in the Q2 2017 versus44.1% and 55.9% of total revenues, respectively, for the same period last year. Net income was $30.4 million versus net income of $21.5 million. The CEO commented:

Our thoughts and prayers go out to everyone affected by hurricane Harvey, including many Dave & Busters employees who have been significantly impacted. We are working to help get them back on their feet as soon as possible. Our three stores in Houston reopened Friday after remaining closed for several days. In terms of the quarter, Dave & Busters disciplined real estate strategy and differentiated product offering continue to pay off. We delivered another successful quarter of revenue growth driven by double-digit unit expansion and positive comparable store sales, a testament to the underlying strength of the brand. Our non-comp store base is performing well and we are very pleased with our recent store openings. Meanwhile, our comparable store sales growth has now exceeded the competitive casual dining benchmark for 21 consecutive quarters.

Hot Performing Stocks To Watch For 2018: Delta Technology Holdings Limited(DELT)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Wednesday, our Under the Radar Moversnewsletter suggested going long on small capChinese chemical stock Delta Technology Holdings Ltd(NASDAQ: DELT):

Hot Performing Stocks To Watch For 2018: XOMA Corporation(XOMA)

Advisors’ Opinion:

  • [By Spencer Israel]

    The following are some of the stocks discussed on the show for which co-host Joel Elconin offered technical levels.

    Bank of America Corp (NYSE: BAC) hit a low last week of $22.43, and has a big psychological level of $22.
    Goldman Sachs Group Inc (NYSE: GS) has two minor support levels from early December of $221.22 and $220.35. Under $220 it gets dicey, with support at $214.97 and $209.92.
    United States Steel Corporation (NYSE: X) has a key low of $31.33 from February 2. That number serves as support.
    Best Buy Co Inc (NYSE: BBY) has a triple top at $45.15. It's currently in a trading range from $43.75-$45.70.
    Shake Shack Inc (NYSE: SHAK) has been range bound over the last four days from $31.68 to $32.62. It has major support at the all-time low from March 15 at $30.36.
    Warren Lorenz, CEO of TechMeetsTrader, joined the show to discuss his "Facebook for stocks" platform, and how he learned how to trade by watching trading communities. Listen to the full interview with Lorenz here.
    Tommy Lackey, managing partner and portfolio manager at Relativity Capital Advisors, told us which stocks are on his nitrous scans and meltdown filters this morning. Those include XOMA Corporation (NASDAQ: XOMA) Whirlpool Corporation (NYSE: WHR) and Bed Bath & Beyond Inc. (NASDAQ: BBBY). Listen to the full interview with Lackey here.
    With the market in a slight selloff following Friday's healthcare fallout, the focus today will be which sectors, if any, rebound throughout the day. With steel stocks looking weak and gold minors and utilities looking strong, co-host Dennis Dick said he'll try to jump into those sectors if they stay weak after the open. Hear what other sectors Dick is watching here.
    With Snap Inc (NYSE: SNAP)'s 25-day quiet period for analysts over, the Street was treated to bullish ratings by Goldman Sachs, Citigroup, Morgan Stanley and others. It's worth noting, however, most of Monday morning

  • [By Lisa Levin]

    Shares of XOMA Corporation (NASDAQ: XOMA) got a boost, shooting up 31 percent to $14.69. Wedbush upgraded XOMA from Neutral to Outperform.

    Energous Corp (NASDAQ: WATT) shares were also up, gaining 17 percent to $11.89. Energous reported a new, high-power, Near Field WattUp charging solution for electronic devices.

Hot Performing Stocks To Watch For 2018: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Hot Performing Stocks To Watch For 2018: Just Hold Your Nose and Dive Into Under Armour Inc (UAA)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    If Under Armour (UAA) , (UA) shareholders didn’t have bad luck, they wouldn’t have any luck at all. UAA shares are down around 30% year to date and more than 50% in the last 12 months. I thought these guys were supposed to be the next Nike (NKE) .

  • [By Ben Levisohn]

    Shares of Under Armour (UAA) have tumbled nearly 60% during the past 12 months as the once high-flying company slashed its expected growth rate. Under Armour is scheduled to report earnings tomorrow, however, and some investors are betting that the release will help turn things around for the company’s stock.

    Jeff Schear/Getty Images for Under Armour

    Don’t get your hopes up, write Canaccord Genuity analysts Camilo Lyon and Pallav Saini, who contend this won’t be the quarter Under Armour turns things around. They explain why:

    The trifecta of headwinds that plagued UA last year (overexposure to sporting goods, overexposure to NA, and overexposure to performance apparel) has not abated, in our opinion. While UA is working to diversify its channel mix as evidenced by its recent entry into Kohl’s (KSS) (and forthcoming entry into DSW (DSW) and Famous Footwear later this year), our checks suggest the apparel segmentation efforts have fallen short of expectations. In addition, we are concerned about the lackluster trends in footwear (and Curry) as it is a key element to the growth story. Specifically, we believe the combination of a lack of newness/differentiation in the Curry 3 coupled with too many releases too soon at a higher price point ($140) resulted in tepid Q1 sales. The latest Curry 3Zero release at $120 appears to be doing modestly better. We highly regard the brand and its long-term growth prospects; however, the product and geographic diversification occurring now will take time to yield results. As such, we remain cautious on UA heading into its 1Q17 report on Thursday, April 27 BMO.

    Shares of Under Armour have gained 1.3% to $19.78 at 3:06 p.m. today, while Kohl’s has climbed 1.4% to $39.92, and DSW has risen 1.3% to $21.14.

  • [By Dustin Blitchok]

    Prior to Wednesday’s unraveling of the manufacturing council, six executives had resigned:

    On June 1, Tesla Inc (NASDAQ: TSLA) CEO Elon Musk dropped out following Trump’s decision to withdraw the U.S. from the Paris climate accord. “Leaving Paris is not good for America or the world,” Musk tweeted.
    Merck & Co., Inc. (NYSE: MRK) CEO Ken Frazier drew fire from Trump on Twitter after leaving the council. “Now that Ken Frazier of Merck Pharma has resigned from President's Manufacturing Council,he will have more time to LOWER RIPOFF DRUG PRICES!" the president tweeted.
    When Frazier left the council, he said: “I feel a responsibility to take a stand against intolerance and extremism.”
    On Aug. 14, Under Armour Inc (NYSE: UAA) CEO Kevin Plank resigned. “I love our country & company,” Plank said. “I am stepping down from the council to focus on inspiring & uniting through power of sport.”
    Intel Corporation (NASDAQ: INTC) CEO Brian Krzanich left Aug. 14 and said: “I stand with others for equality and improving U.S. competitiveness. Both require improving in today’s environment.”
    Alliance for American Manufacturing President Scott Paul quit Aug. 15, stating: “I’m resigning from the Manufacturing Jobs Initiative because it’s the right thing for me to do.”
    AFL-CIO President Richard Trumka resigned the same day as Paul. “We cannot sit on a council for a president who tolerates bigotry and domestic terrorism,” Trumka said.

    Image: Gage Skidmore, Flickr

Hot Performing Stocks To Watch For 2018: Progressive Corporation (The)(PGR)

Advisors’ Opinion:

  • [By Chris Lange]

    Progressive Corp. (NYSE: PGR) is set to report its third-quarter results Tuesday morning as well. The analysts consensus estimates are $0.36 in EPS on revenue of $6.99 billion. Shares were changing hands at $48.67 on Fridays close. The consensus price target is $49.07, and the 52-week range is $30.99 to $49.75.

define investment

Leave a reply

UBS analyst Michael Binetti and team warn investors not to get too excited about Urban Outfitters’ (URBN) same-store-sales surprise:

Reuters

1Q SSS Trending +LSDbut Noisy; Raising Our 1Q SSS Estimate Slightly: We’re raising our 1Q SSS to flat from -1% previously. In its FY16 (Jan-16 end) 10K filing on 3/31,Urban Outfitters reported its 1Q17 (Jan-17 end) SSS are trending +LSD. We believe trends are at the low end of +LSD (likely +1%)and we estimate that the Feb+Mar period gets a +1-1.5pp lift from an extra day vs LY (Unlike most other specialty retailers that report 4-5-4 week quarters,Urban Outfitters is based on a true calendar monthso Leap Yr is incremental). On our math,Urban Outfitters’ underlying trend is likely close to flat in Feb+Mar. April should be a lower volume month in the qtr, but visibility into April trends for the industry is low. An Easter shift into March (vs Easter in April last year) is a headwind to Apriland April weather could be unfavorable YOY (based on comments from our 3/29 weather expert conference call).That said, based on our conversation with the company we believe that compares should ease in the back half of April, which could offset other headwinds.

define investment: PAR Technology Corporation(PAR)

Advisors’ Opinion:

  • [By Lisa Levin]

    On Tuesday, technology shares gained by 1.61 percent. Meanwhile, top gainers in the sector included Himax Technologies, Inc. (ADR) (NASDAQ: HIMX), up 13 percent, and PAR Technology Corporation (NYSE: PAR), up 9 percent.

  • [By Lisa Levin]

    PAR Technology Corporation (NYSE: PAR) shares were also up, gaining 15 percent to $6.59. Par Technology reported Q4 adjusted earnings of $0.13 per share on revenue of $56.8 million.

define investment: Ambarella, Inc.(AMBA)

Advisors’ Opinion:

  • [By Leo Sun]

    Ambarella (NASDAQ:AMBA) is primarily known for supplying image processing SoCs (system on chips) for GoPro’s (NASDAQ:GPRO) action cameras. As a result, Ambarella’s stock often rose and fell with GoPro’s in the past.

  • [By Sreekanth Anasa]

    Can Q3 earnings lift Ambarella Inc (NASDAQ:AMBA) stock?

    Shares of semiconductor design company Ambarella Inc (NASDAQ:AMBA) are sliding down ahead of earnings, closing in the red for consecutive three straight trading sessions. The company whose technology is behind the low power, high-definition and ultra HD video compression and image processing products,is scheduled to report its fiscal 2018 third-quarter earnings today after the closing bell. AMBA stock has not gone anywhere since its last earnings release and is almost flat but it is losing momentumgoing into earnings, down nearly 7% in the last 5 trading days. This brings us to the question, can earnings lift Ambarella stock? The technical setup has also turned little bearish recently. Will earnings help stem the downtrend in Ambarella stock? Well, first, let’s take a look at the analyst estimates.

  • [By Peter Graham]

    Ambarella, Inc. (AMBA) has been all over the map over the last few years. It has defied gravity both to the up and to the downside, and although today’s suggested short of the stock is strictly technical, we do believe its current share price has once again gotten a little out of line when you compare it to the rest of the markets’ valuation metrics right now.

  • [By Lisa Levin]

    Shares of Ambarella Inc (NASDAQ: AMBA) got a boost, shooting up 19 percent to $64.32 after the company reported stronger-than-expected results for its third quarter.

define investment: Insignia Systems, Inc.(ISIG)

Advisors’ Opinion:

  • [By Lisa Levin]

    Shares of Insignia Systems, Inc. (NASDAQ: ISIG) were down 18 percent to $1.45. Insignia Systems announced a 2.313 million share common stock offering via selling holders.

  • [By Lisa Levin]

    Shares of Insignia Systems, Inc. (NASDAQ: ISIG) were down 20 percent to $1.41. Insignia Systems announced a 2.313 million share common stock offering via selling holders.

define investment: Sirius XM Radio Inc.(SIRI)

Advisors’ Opinion:

  • [By Rick Munarriz]

    There are a lot of people betting against Sirius XM Radio (NASDAQ:SIRI)these days, even as the stock is hitting 10-year highs. There were 280.1 million shares of Sirius XM sold short at the end of 2016, just below the late-November peak of 285.1 million shares but nearly double the short interest that we were seeing a year ago.

  • [By Jon C. Ogg]

    The long saga regarding Pandora Media Inc. (NYSE: P) has finally come to a head. Well, maybe. Rather than KKR & Co. L.P. (NYSE: KKR) investing $150 million, Sirius XM Holdings Inc. (NASDAQ: SIRI) will be investing up to $480 million in the streaming music rival. With its ticketing unit sale taking place as well, it might seem that Pandora is getting a great deal and helping to bolster its books.

  • [By Ashley Moore]

    But before we get to the stock pick, here’s a list of the 10 top-performing Warren Buffett stocks so far this year…

    Company YTD Gains
    Moody’s Corp. (NYSE: MCO) 34.25%
    Apple Inc. (Nasdaq: AAPL) 30.24%
    Verisign Inc. (Nasdaq: VRSN) 29.88%
    Restaurant Brands Inc. (NYSE: QSR) 29.16%
    WABCO Holdings Inc. (NYSE: WBC) 28.97%
    Visa Inc. (NYSE: V) 26.20%
    Liberty Sirius XM Group Class C (Nasdaq: LSXMK) 24.54%
    MasterCard Inc. (NYSE: MA) 24.35%
    Liberty Sirius XM Group Class A (Nasdaq: LSXMA) 22.89%
    Sirius XM Holdings Inc. (Nasdaq: SIRI) 22.81%

    Again, we don’t recommend all of the stocks above for retail investors. After all, Warren Buffett is one of the most wealthy and legendary investors in history. He has a completely different set of goals from us.

  • [By Peter Graham]

    A long term performance chart shows Pandora Mediapeaking in 2014 before heading back to where it started while other streaming media stocks such as large cap satellite radio stockSirius XM Radio Inc (NASDAQ: SIRI) has performed better and InternetTV stock Netflix, Inc (NASDAQ: NFLX) has been a homerun:

define investment: Insulet Corporation(PODD)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation peaking in 2014 before falling below the more steady performance of diabetes or insulin stocks like large cap Novo Nordisk A/S (NYSE: NVO) and small cap Insulet Corporation (NASDAQ: PODD):

  • [By Peter Graham]

    A long term performance chart shows MannKind Corporation having once been a highflyerwhile the performance of large cap insulin and diabetes stockNovo Nordisk A/S (NYSE: NVO) has fallen off and small cap Insulet Corporation (NASDAQ: PODD) has actually performed better:

  • [By Brian Feroldi]

    Shares of Insulet Corporation(NASDAQ:PODD), a medical device company primarily focused on diabetes,rose by as much as 11% in afternoon trading on Friday.

define investment: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Top 10 Stocks To Own For 2018

Leave a reply

Dick’s Sporting Goods (NYSE:DKS) and Big 5 Sporting Goods (NASDAQ:BGFV) have both had a great 2016. As far as stock performance goes, Big 5 is the winner this year. But which company is in better shape for the new year?

Data source: YCharts..

Riding a wave of positive news

Both companies have benefited during the pastyear from a couple of positive developments. First up, the now ironically named Sports Authority went out of business. The former competitor entered bankruptcy anticipating reemerging a stronger business. That didn’t happen, and no savior stepped in to rescue the failed retailer. A fire sale ensued, and the company’s stores shut down, leaving remaining sports merchandisers to pick up the pieces.

In addition to that development, consumer spending on sporting goods rose during the year. According to the U.S. Census Bureau, sales of sports merchandise rose 3.7% over 2015 through the end of November. Those two factors contributed to both companies, posting positive sales growth even as brick-and-mortar retail, in general, struggled this year.

Top 10 Stocks To Own For 2018: Tetra Technologies, Inc.(TTI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Energy sector was the top gainer in the US market on Wednesday. Top gainers in the sector included TETRA Technologies, Inc. (NYSE: TTI), CARBO Ceramics Inc. (NYSE: CRR), and Atwood Oceanics, Inc. (NYSE: ATW).

  • [By Lisa Levin]

    Wednesday afternoon, the energy sector proved to be a source of strength for the market. Leading the sector was strength from TETRA Technologies, Inc. (NYSE: TTI) and Abraxas Petroleum Corp. (NASDAQ: AXAS).

Top 10 Stocks To Own For 2018: Omega Protein Corporation(OME)

Advisors’ Opinion:

  • [By Lisa Levin]

    Omega Protein Corporation (NYSE: OME) was down, falling around 20 percent to $17.47 after the company reported weaker-than-expected results for its fourth quarter.

  • [By Lisa Levin]

    Omega Protein Corporation (NASDAQ: OME) shares dropped 21 percent to $20.65 after the company posted weak Q4 earnings.

    Shares of Endeavour Silver Corp (NYSE: EXK) were down around 22 percent to $3.41. Endeavour Silver reported a Q4 loss of $5.2 million.

Top 10 Stocks To Own For 2018: MGM Resorts International(MGM)

Advisors’ Opinion:

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Avon Products, Inc. (NYSE: AVP) to report quarterly earnings at $0.10 per share on revenue of $1.62 billion before the opening bell. Avon Products shares rose 2.39 percent to $6.00 in after-hours trading.
    Analysts expect MGM Resorts International (NYSE: MGM) to report quarterly earnings at $0.20 per share on revenue of $2.44 billion before the opening bell. MGM shares rose 1.01 percent to $29.90 in after-hours trading.
    Cisco Systems, Inc. (NASDAQ: CSCO) reported better-than-expected results for its second quarter and raised its quarterly dividend to $0.29 per share. Cisco shares rose 2.13 percent to $33.52 in the after-hours trading session.
    Before the markets open, Dean Foods Co (NYSE: DF) is projected to report its quarterly earnings at $0.41 per share on revenue of $2.01 billion. Dean Foods shares rose 0.49 percent to $20.55 in after-hours trading.
    Tripadvisor Inc (NASDAQ: TRIP) posted weaker-than-expected results for its fourth quarter on Wednesday. Tripadvisor shares dropped 5.60 percent to $49.75 in the after-hours trading session.
    Analysts are expecting Waste Management, Inc. (NYSE: WM) to have earned $0.77 per share on revenue of $3.42 billion in the latest quarter. Waste Management will release earnings before the markets open. Waste Management shares rose 2.27 percent to $72.97 in after-hours trading.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Ben Levisohn]

    MGM Resorts International (MGM) always had two things going for it: It’s large Las Vegas footprint to counter the weakness in Macau, and it’s real-estate, which it spun off into MGM Growth Properties (MGP). But when MGM reported weaker than expected earnings this morning, it wasn’t a good sign that Las Vegas was disappointing. Wells Fargo’sCameron McKnight explains:

    Getty Images

    Q4 Las Vegas EBITDA of $365mm was 10% ($40MM) below the Street. Las Vegas 4Q RevPAR growth of +3% was in-line with guidance, but below our expectations and industry data. For the 1Q17, MGM provided RevPAR guidance of 7%, a point or two below our expectations. We estimate revenue growth per visitor was +1.5% yr/yr. RevPOR (other revenue per occupied room) growth was +1.5%. We estimate expenses were +1% yr/yr. We expect the stock to be trade down on this morning’s release. While forward guidance was tepid, MGM missed Las Vegas expectations.

    Shares of MGM Resorts International have tumbled 7.3% to $27.45 at 11:37 a.m. today, while MGM Resorts Properties has declined 0.3% to $25.58.

  • [By Wayne Duggan]

    According to Deutsche Bank analyst Carlo Santarelli, news that Las Vegas Sands Corp. (NYSE: LVS) may be selling its Sands Bethlehem resort to MGM Resorts International (NYSE: MGM) could be a win-win-win for Sands, MGM and MGM Growth Properties LLC (NYSE: MGP).

Top 10 Stocks To Own For 2018: Inogen, Inc(INGN)

Advisors’ Opinion:

  • [By Michael A. Robinson]

    I put these rules in action for you in March 2015 when I recommendedInogen Inc.(Nasdaq: INGN)here in these pages.

    Inogen is pioneering the use of portable oxygen concentrators (POCs). And theGoleta, Calif.-based firm boasts breakthrough technology that has disrupted its entire sector.

Top 10 Stocks To Own For 2018: Celestica, Inc.(CLS)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of small cap Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newsletter suggestion as the next breakout stock, andmid cap Flextronics International being bigger winners compared with the also good performance of mid cap Jabil Circuit, Inc (NYSE: JBL) and small cap Celestica Inc (NYSE: CLS):

  • [By Peter Graham]

    A long term performance chart shows shares of mid caps Jabil Circuit and Flextronics International Ltd (NASDAQ: FLEX) along with small capCelestica Inc (NYSE: CLS) and Sanmina Corp (NASDAQ: SANM), a previous Elite Opportunity Pro (EOP) newslettersuggestion as the next breakout stock, all performing well recently as the tech stocks they supply outperform:

Top 10 Stocks To Own For 2018: Lannett Co Inc(LCI)

Advisors’ Opinion:

  • [By Lisa Levin]

    Breaking news

    Edwards Lifesciences Corp (NYSE: EW) announced plans to buy Valtech Cardio for $340 million in cash and stock. The company also announced a $1 billion buyback plan.
    Epizyme Inc (NASDAQ: EPZM) disclosed that it has received Fast Track designation for tazemetostat.
    Athene Holding Ltd. (NYSE: ATH) reported that it has priced its 23.8 million share IPO between $38 per share and $42 per share.
    Lannett Company, Inc. (NYSE: LCI) reported the approval for its Metaxalone Tablets USP, 800 mg.

  • [By Peter Graham]

    Small cap generic pharmaceutical stock Lannett Company, Inc (NYSE: LCI) is thethird most shorted stock on the NYSE with short interest of 52.86% according toHighshortinterest.com.Lannett Company, founded in 1942, develops, manufactures, packages, markets and distributes generic pharmaceutical products for a wide range of medical indications and therapeutic areas. The Company believe that its ability to select viable products for development, efficiently develop such products (including obtaining any applicable regulatory approvals), vertically integrateitself into certain specialty markets and achieve economies in production are all critical for its success in the generic pharmaceutical industry in which it operates.

  • [By Ashley Moore]

    We’ve compiled a list of the most heavily shorted stocks to show you which stocks have the most negative sentiment on the market…

    Company Name (Ticker)Short FloatShare PriceHanwha Q Cells Co. Ltd. (Nasdaq ADR: HQCL)98.52%$ 8.88Renren Inc. (NYSE: RENN)91.59%$ 8.53Weight Watchers International Inc. (NYSE: WTW)67.92%$12.57INSYS Therapeutics Inc. (Nasdaq: INSY)66.71%$10.74Twilio Inc. (NYSE: TWLO)66.34%$33.17Nutanix Inc. (Nasdaq: NTNX)65.65%$31.96Fitbit Inc. (NYSE: FIT)55.15%$ 6.06Weibo Corp. (Nasdaq ADR: WB)53.83%$55.26RPC Inc. (NYSE: RES)53.62%$21.19Straight Path Communications Inc. (NYSEMKT: STRP)49.27%$34.79Momo Inc. (Nasdaq ADR: MOMO)48.63%$26.80Seritage Growth Properties (NYSE: SRG)46.91%$44.87Lannett Company Inc. (NYSE: LCI)45.46%$23.00Gogo Inc. (Nasdaq: GOGO)43.98%$ 9.10Altisource Portfolio Solutions SA (Nasdaq: ASPS)42.78%$22.73Cheetah Mobile Inc. (NYSE ADR: CMCM)40.86%$10.00

    Some investors think the only way to profit from the stock market is to buy stocks and wait for the price to rise. However, these investors are missing out on the massive profit opportunity that comes from shorting stocks.

Top 10 Stocks To Own For 2018: Rayonier Advanced Materials Inc.(RYAM)

Advisors’ Opinion:

  • [By Travis Hoium]

    Shares of materials company Rayonier Advanced Materials Inc (NYSE:RYAM) jumped as much as 11.8% in trading Thursday after announcing a major acquisition. At 3:30 p.m. EDT, the shares were holding at a 10.6% gain on the day.

Top 10 Stocks To Own For 2018: Peregrine Pharmaceuticals Inc.(PPHM)

Advisors’ Opinion:

  • [By Alex McGuire]

    Here’s a list of the top 10 penny stocks to watch in March, which includes the biggest gainers last month…

    Penny StockCurrent Stock PriceFebruary 2017 ReturnZosano Pharma Corp. (Nasdaq: ZSAN)$2.56+123.3%Bellerophon Therapeutics Inc. (Nasdaq: BLPH)$1.25+113.8%Peregrine Pharmaceuticals (Nasdaq: PPHM)$0.59+101.7%Galectin Therapeutics Inc. (Nasdaq: GALT)$1.79+91.9%Bioanalytical Systems Inc. (Nasdaq: BASI)$1.58+90.6%CymaBay Therapeutics Inc. (Nasdaq: CBAY)$3.50+89.8%Vermillion Inc. (Nasdaq: VRML)$2.56+86.3%Naked Brand Group Inc.(Nasdaq:NAKD)$2.16+76%Eyegate Pharmaceuticals Inc. (Nasdaq: EYEG)$2.63+73.9%Benitec Biopharma Ltd. (Nasdaq ADR: BNTC)$2.60+59.9%

    The best-performing penny stock – Zosano Pharma Corp. – soared an incredible 123.3% from Feb. 1 to Feb. 28. To put those gains into perspective, that’s more than five times the S&P 500’s 23% climb in the last 12 months.

Top 10 Stocks To Own For 2018: Deutsche Bank AG(DB)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    Today, Deutsche Bank (DB) pretty much signals an all-clear based on that call and says things are indeed getting better. So there are buyers all over the place.

  • [By Diane Alter]

    The New York Times first reported that Frontier Airlines is prepping for an initial public offering. The Denver, Colo.-based low-cost carrier has hired Deutsch Bank (NYSE: DB), JPMorgan Chase & Co. (NYSE: JPM), and Evercore Partners Inc. (NYSE: EVR) to handle the IPO. The airline started the process late last year when it approached a number of bankers.

  • [By Lisa Levin]

    Monday afternoon, the non-cyclical consumer goods & services sector proved to be a source of strength for the market. Leading the sector was strength from Deutsche Bank AG (USA) (NYSE: DB) and Banco Bilbao Vizcaya Argentaria SA (ADR) (NYSE: BBVA).

Top 10 Stocks To Own For 2018: Staples, Inc.(SPLS)

Advisors’ Opinion:

  • [By Rich Duprey]

    A few years ago, office-supplies retailerStaples(NASDAQ:SPLS)and electronics store RadioShack thought they could benefit from the e-tailer’s sales prowess. Although they were losing sales regularly to Amazon, they thoughtplacing lockersin their stores could also result in the sale of an extra ream of paper or a few capacitors and potentiometers. Instead what they found was customers were simply buying their paper, ink cartridges, and electronic gadgets on Amazon and picking them up in their stores. After just a year, Staples and RadioShack abruptly ended the program.

  • [By Javier Hasse]

    Multiple-award-winning Trimaker is the leader in terms of sales in 3D printing in the region, serving clients like Staples, Inc. (NASDAQ: SPLS), Toyota Motor Corp (ADR) (NYSE: TM), Kraft Heinz Co (NASDAQ: KHC) and Telefonica S.A. (ADR) (NYSE: TEF). The company not only manufactures its own 3D printers, but also offers materials and related services.

  • [By Ben Levisohn]

    Staples (SPLS) soared to the top of the S&P 500 today on reports that the office-supplies retailer was considering selling itself.

    Agence France-Presse/Getty Images

    Staples gained 9.8% to $9.51 today, while the S&P 500 ticked up 0.1% to 2,360.16.

    CFRA’s Efraim Levy doesn’t see a “natural buyer” for Staples but remain Buy rated anyway:

    Shares are higher on an unconfirmed WSJ report that SPLS is looking at the possible sale of the company. Our fundamentally valued 12-month target of $11, applies a below historical average P/E of 12.1X our FY 18 EPS estimate, given office industry challenges. Our target has 11% upside, plus a 5.5% yield. We don’t see a natural buyer for a large physical store office supply presence, although an activist/private-equity buyer is a possibility. To make an acquisition worthwhile, a buyer would have to be more aggressive in cost cutting and use of cash flow than SPLS’s existing plan.

    Staples’ market capitalization rose to $6.2 billion today from $5.7 billion yesterday. It reported a net loss of $459 million on sales of $18.2 billion in fiscal 2017.

  • [By Lisa Levin]

    Staples, Inc. (NASDAQ: SPLS) posted weaker-than-expected earnings for its fourth quarter.

    Staples reported Q4 adjusted earnings of $0.25 per share on revenue of $4.56 billion. Analysts were expecting earnings of $0.26 per share on revenue of $5 billion.